Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients

被引：0
|
作者：
Khamash, H. [1 ]
Mannon, R. [1 ]
Hanaway, M. [1 ]
Gaston, R. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1555
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [21] Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [22] Incidence and Severity of Leukopenia/Neutropenia in Kidney Transplant Recipients Following Single Dose Alemtuzumab Induction: A Prospective Review of 232 Patients.
    Smith, A.
    Couvillion, R.
    Zhang, R.
    Killackey, M.
    Buell, J.
    Saggi, B.
    Lee, B.
    Paramesh, A.
    TRANSPLANTATION, 2014, 98 : 578 - 578
  • [23] Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin
    Thibaudin, D
    Alamartine, E
    de Filippis, JP
    Diab, N
    Laurent, B
    Berthoux, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (03) : 711 - 715
  • [24] Incidence and Severity of Leukopenia/Neutropenia in Kidney Transplant Recipients Following Single Dose Alemtuzumab Induction: A Prospective Review of 232 Patients.
    Smith, A.
    Couvillion, R.
    Zhang, R.
    Killackey, M.
    Buell, J.
    Saggi, B.
    Lee, B.
    Paramesh, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 578 - 578
  • [25] Efficacy and Safety of Extended-Duration Inpatient-to-Outpatient Rabbit Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients: 6-Month Outcomes
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Patel, Hina J.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Bloom, Roy D.
    TRANSPLANTATION, 2012, 94 (05) : 506 - 512
  • [26] Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab
    Pham, Christine
    Kuten, Samantha A.
    Knight, Richard J.
    Nguyen, Duc T.
    Graviss, Edward A.
    Gaber, A. Osama
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (03)
  • [27] A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
    Schweiger, Martin
    Zuckermann, Andreas
    Beiras-Fernandez, Andres
    Berchtold-Herz, Michael
    Boeken, Udo
    Garbade, Jens
    Hirt, Stephan
    Richter, Manfred
    Ruhpawar, Arjang
    Schmitto, Jan Dieter
    Schoenrath, Felix
    Schramm, Rene
    Schulz, Uwe
    Wilhelm, Markus J.
    Barten, Markus J.
    ANNALS OF TRANSPLANTATION, 2018, 23 : 322 - 333
  • [28] Incidence and Management of Leukopenia/Neutropenia in 233 Kidney Transplant Patients Following Single Dose Alemtuzumab Induction
    Smith, A.
    Couvillion, R.
    Zhang, R.
    Killackey, M.
    Buell, J.
    Lee, B.
    Saggi, B. H.
    Paramesh, A. S.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3400 - 3404
  • [29] Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 329
  • [30] Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
    Lam, Ngan N.
    Jeong, Rachel
    Quinn, Robert R.
    Ravani, Pietro
    Xiao, Huiling
    McAdams-DeMarco, Mara
    Axelrod, David A.
    Schnitzler, Mark A.
    Snyder, Jon J.
    Lentine, Krista L.
    TRANSPLANTATION DIRECT, 2021, 7 (08): : E736
12345